FDA Approves Portrazza to Treat Advanced Squamous Non-small Cell Lung Cancer

News Release FDA

首页> 外文期刊>Molecular and Cellular Pharmacology >FDA Approves Portrazza to Treat Advanced Squamous Non-small Cell Lung Cancer

【24h】

FDA Approves Portrazza to Treat Advanced Squamous Non-small Cell Lung Cancer

机译：FDA批准Portrazza治疗晚期鳞状非小细胞肺癌

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer. ….(click PDF to read more) Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:150%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}

机译：美国食品药品监督管理局今天批准Portrazza（necitumumab）与两种化疗形式联合用于治疗晚期（转移性）鳞状非小细胞肺癌（NSCLC）的患者，这些患者以前未曾接受过专门用于治疗晚期肺癌的药物。 …。（单击PDF以了解更多信息）正常0否否否EN-US X-NONE X-NONE / *样式定义* / table.MsoNormalTable {mso-style-name：“ Table Normal”; mso-tstyle-rowband-size：0; mso-tstyle-colband-size：0; mso-style-noshow：是; mso-style-priority：99; mso-style-parent：“”; mso-padding-alt：0in 5.4pt 0in 5.4pt; mso-para-margin-top：0in; mso-para-margin-right：0in; mso-para-margin-bottom：10.0pt; mso-para-margin-left：0in;行高：150％; mso分页：寡妇孤儿;字体大小：12.0pt;字体家族：“ Calibri”，“ sans-serif”; mso-ascii-font-family：Calibri; mso-ascii-theme-font：minor-latin; mso-hansi-font-family：Calibri; mso-hansi-theme-font：minor-latin;}

著录项

来源
《Molecular and Cellular Pharmacology》 |2015年第2期|共2页
作者
News Release FDA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. P2.01-03 Quality of Life Outcomes for FDA-Approved Agents in Advanced Non-Small Cell Lung Cancer [J] . H. Albaba, A. Bezjak, N. Leighl Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P2.01-03先进的非小细胞肺癌中FDA批准药剂的生活质量结果
2. Non-small Cell Lung Cancer (NSCLC) Necitumumab in advanced squamous NSCLC approved with EGFR-Expression [J] . Sankawa Yuri Oncology research and treatment. . 2016,第6期

机译：EGFR表达批准的晚期鳞状非小细胞肺癌非小细胞肺癌（NSCLC）尼珠单抗
3. CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations [J] . Felip Enriqueta, Ardizzoni Andrea, Ciuleanu Tudor, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第期

机译：Cheemmate 171：先前治疗先前治疗的晚期鳞状非小细胞肺癌，包括ECOG PS 2和老年人口的患者患者患者的第2期试验
4. Adenylyl Cyclase-Associated Protein 1 in Metastasis of Squamous Cell Carcinoma of the Head and Neck and Non-Small Cell Lung Cancer [C] . G. V. Kakurina, E. S. Kolegova, O. V. Cheremisina, International Conference on Physics of Cancer . 2016

机译：腺苷酸环酶相关蛋白1在头部和颈部和非小细胞肺癌的鳞状细胞癌转移中
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Portrazza (Necitumumab) an IgG1 Monoclonal Antibody FDA Approved for Advanced Squamous Non–Small-Cell Lung Cancer [O] . Loretta Fala 2016

机译：FDA批准Portrazza（Necitumumab）IgG1单克隆抗体用于晚期鳞状非小细胞肺癌
7. P2.01-03 Quality of Life Outcomes for FDA-Approved Agents in Advanced Non-Small Cell Lung Cancer [O] . H. Albaba, A. Bezjak, N. Leighl 2018

机译：P2.01-03先进的非小细胞肺癌中FDA批准药剂的生活质量结果

FDA Approves Portrazza to Treat Advanced Squamous Non-small Cell Lung Cancer

摘要

著录项

相似文献

相关主题

期刊订阅